India, Sept. 1 -- Medincell S.A. (MEDCL.PA), a clinical- and commercial-stage biopharmaceutical company, on Tuesday announced the appointment of Edna Venneker, as Chief Medical Officer (CMO).
Venneker brings extensive drug development experience across clinical and non-clinical strategy, regulatory affairs, program execution and portfolio management. She most recently served as Head of Development and Senior Vice President at Grunenthal, overseeing clinical development, clinical operations, CMC, data science and advanced analytics.
She previously served as Deputy Chief Medical Officer and was a member of Grunenthal's R&D Leadership Team and R&D Portfolio Board. Her experience spans small molecules, biologics, vaccines and advanced therapi...